Processa Pharmaceuticals, Inc.
USD1.96
+0.10 (+5.38%)
CEO
George K. Ng
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.91
Prev. Close
$1.86
Day Low
$1.81
Day High
$2.04
52W Low
$1.76
52W High
$14.25
Market Cap
$0.00B
Volume
0.03M
| 2,654 |
| $2.22 |
| 16 Jun 2026 | Ng George K | director, officer: Chief Executive Officer | P-Purchase | Acquired | 2,465 | $2.22 |
| 16 Jun 2026 | Lin Patrick | Chief Business - Strategy Off | P-Purchase | Acquired | 1,831 | $2.22 |
| 16 Jun 2026 | Guy Wendy | Chief Administrative Officer | P-Purchase | Acquired | 2,118 | $2.22 |
| 1 Jun 2026 | Young David | director, officer: Pres. Research & Development | P-Purchase | Acquired | 1,786 | $2.57 |
| 1 Jun 2026 | SKIBSTED RUSSELL | Chief Financial Officer | P-Purchase | Acquired | 2,292 | $2.57 |
| 1 Jun 2026 | Ng George K | director, officer: Chief Executive Officer | P-Purchase | Acquired | 2,129 | $2.57 |
| 1 Jun 2026 | Lin Patrick | Chief Business - Strategy Off | P-Purchase | Acquired | 1,582 | $2.57 |
| 1 Jun 2026 | Guy Wendy | Chief Administrative Officer | P-Purchase | Acquired | 1,829 | $2.57 |